Pylarify - 1 year contract (10/01/2023 - 09/30/2024)
Ended Awarded Last action
- Contract number
- 36C25024F0010
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,030,850
Award facts
- Opportunity
-
- 6505--F-18 Pylarify / Piflufolastat - Injectable Radiopharmaceutical Ann Arbor - Nuclear Medicine Brand Name Only Special Notice · 36C25024Q0013 · Posted Sep 6, 2023
- Contract value 100% obligated
- $1,030,850.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$85,673 | |
| Supplemental Agreement for work within scope | $216,523 | |
| Original award | $900,000 |
About this award
The U.S. Department of Veterans Affairs (VA) awarded a 1-year, firm fixed-price delivery order worth $1,030,850.32 to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. This contract is for the provision of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The award was not set aside for any specific business type.
Progenics Pharmaceuticals is a subsidiary of the parent company Lantheus Holdings, Inc., which specializes in developing and supplying innovative diagnostic and therapeutic agents, including a range of radiopharmaceuticals, to federal agencies such as the VA, Defense Health Agency (DHA), and National Institutes of Health (NIH) Clinical Center. The company holds several Indefinite Delivery Vehicles (IDVs), including Blanket Purchase Agreements (BPAs), on the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) that facilitate ongoing procurement of its products by various government healthcare providers.
Quick answers
Who was awarded contract 36C25024F0010?
36C25024F0010 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C25024F0010 worth?
The government has obligated $1,030,850 on 36C25024F0010.
Is contract 36C25024F0010 an order under another contract?
Yes. 36C25024F0010 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25024F0010 competed?
The extent of competition for 36C25024F0010 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award